CC
Schedule 13D filing
Choo Chee Kong disclosed a 25.2% stake in CytoMed Therapeutics Ltd (GDTC)
Choo Chee Kong reported owning 25.2% of CytoMed Therapeutics Ltd (GDTC) (3,003,996 shares) in a Schedule 13D filed Oct 16, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Oct 16, 2026
- Source
- Schedule 13D
More GDTC insider and Congress trades
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.